Rowan Hardy

3.1k total citations · 1 hit paper
58 papers, 2.3k citations indexed

About

Rowan Hardy is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Rowan Hardy has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Rowan Hardy's work include Hormonal Regulation and Hypertension (28 papers), Adrenal Hormones and Disorders (28 papers) and Pharmacological Effects of Natural Compounds (9 papers). Rowan Hardy is often cited by papers focused on Hormonal Regulation and Hypertension (28 papers), Adrenal Hormones and Disorders (28 papers) and Pharmacological Effects of Natural Compounds (9 papers). Rowan Hardy collaborates with scholars based in United Kingdom, Australia and United States. Rowan Hardy's co-authors include Mark S. Cooper, Karim Raza, Ramon Langen, Justine Webster, Markus J. Seibel, Paul M. Stewart, Hong Zhou, L M Nadler, Philip Stashenko and S F Schlossman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Rowan Hardy

54 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammation and Skeletal Muscle Wasting During Cachexia

2020 232 citations Justine Webster, Rowan Hardy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rowan Hardy United Kingdom	26	701	633	343	316	277	58	2.3k
Fei‐Yan Deng China	27	1.3k 1.9×	230 0.4×	289 0.8×	250 0.8×	407 1.5×	145	2.7k
R. Bouillon Belgium	30	840 1.2×	762 1.2×	426 1.2×	426 1.3×	432 1.6×	70	4.2k
A. Ederveen Netherlands	28	716 1.0×	373 0.6×	191 0.6×	134 0.4×	336 1.2×	58	2.0k
Dana Gaddy United States	26	1.4k 2.0×	230 0.4×	161 0.5×	308 1.0×	785 2.8×	74	2.6k
Robert Gyurko United States	25	848 1.2×	313 0.5×	454 1.3×	669 2.1×	122 0.4×	42	2.8k
Masahiro Sakata Japan	35	1.1k 1.6×	160 0.3×	470 1.4×	301 1.0×	498 1.8×	162	3.5k
Hiroo Niimi Japan	24	463 0.7×	435 0.7×	162 0.5×	182 0.6×	110 0.4×	101	1.7k
Malin C. Erlandsson Sweden	25	632 0.9×	142 0.2×	710 2.1×	139 0.4×	379 1.4×	84	1.9k
Jun Asai Japan	26	986 1.4×	291 0.5×	345 1.0×	189 0.6×	768 2.8×	78	2.7k
Keith Burling United Kingdom	23	509 0.7×	184 0.3×	174 0.5×	416 1.3×	98 0.4×	65	1.6k

Countries citing papers authored by Rowan Hardy

Since Specialization

Citations

This map shows the geographic impact of Rowan Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rowan Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rowan Hardy more than expected).

Fields of papers citing papers by Rowan Hardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rowan Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rowan Hardy. The network helps show where Rowan Hardy may publish in the future.

Co-authorship network of co-authors of Rowan Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Rowan Hardy. A scholar is included among the top collaborators of Rowan Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rowan Hardy. Rowan Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mahida, Rahul Y., Siân Lax, Christopher Bassford, et al.. (2023). Impaired alveolar macrophage 11β-hydroxysteroid dehydrogenase type 1 reductase activity contributes to increased pulmonary inflammation and mortality in sepsis-related ARDS. Frontiers in Immunology. 14. 1159831–1159831. 9 indexed citations

Favero, Vittoria, Alessandro Prete, Yasir Elhassan, et al.. (2023). Inflammation-based scores in benign adrenocortical tumours are linked to the degree of cortisol excess: a retrospective single-centre study. European Journal of Endocrinology. 189(5). 517–526. 7 indexed citations

Webster, Justine, Wouter R. P. H. van de Worp, Marco Kelders, et al.. (2023). 11β-HSD1 determines the extent of muscle atrophy in a model of acute exacerbation of COPD. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(4). L400–L412. 1 indexed citations

O’Neil, John D., Sally A. Clayton, Samuel Lara‐Reyna, et al.. (2023). Dexamethasone impairs the expression of antimicrobial mediators in lipopolysaccharide-activated primary macrophages by inhibiting both expression and function of interferon β. Frontiers in Immunology. 14. 1190261–1190261. 5 indexed citations

Phan, Truong San, et al.. (2023). Local glucocorticoid synthesis regulates house dust mite-induced airway hypersensitivity in mice. Frontiers in Immunology. 14. 1252874–1252874. 1 indexed citations

Nicholson, Thomas, et al.. (2023). Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges. Pharmaceutics. 15(1). 237–237. 4 indexed citations

Cooper, Mark S., et al.. (2021). Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe. Frontiers in Endocrinology. 12. 733611–733611. 15 indexed citations

Fenton, Chloe, Craig Doig, Amy J. Naylor, et al.. (2019). 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy. Arthritis Research & Therapy. 21(1). 188–188. 32 indexed citations

Fenton, Chloe, J. Matthew Webster, Corinna Wehmeyer, et al.. (2019). Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis. Arthritis Research & Therapy. 21(1). 182–182. 26 indexed citations

10.

Hardy, Rowan, Chloe Fenton, Adam P. Croft, et al.. (2018). 11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis. Journal of Autoimmunity. 92. 104–113. 26 indexed citations

11.

Hardy, Rowan, Hong Zhou, Markus J. Seibel, & Mark S. Cooper. (2018). Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy. Endocrine Reviews. 39(5). 519–548. 179 indexed citations

12.

Nanus, Dominika E., Andrew Filer, Lorraine Yeo, et al.. (2015). Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis. Arthritis Research & Therapy. 17(1). 121–121. 12 indexed citations

13.

Juárez, Maria, Emmanuel Karouzakis, Rowan Hardy, et al.. (2013). Early rheumatoid arthritis and resolving fibroblasts segregate according to Dickkopf related protein 1 expression. The Lancet. 381. S57–S57. 2 indexed citations

14.

Li, Aiqing, et al.. (2013). Deletion of Mesenchymal Glucocorticoid Receptor Attenuates Embryonic Lung Development and Abdominal Wall Closure. PLoS ONE. 8(5). e63578–e63578. 36 indexed citations

15.

Hardy, Rowan, Christopher M. Jones, Dominika E. Nanus, et al.. (2012). Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells. Arthritis & Rheumatism. 64(7). 2404–2413. 41 indexed citations

16.

Hardy, Rowan, Karim Raza, & Mark S. Cooper. (2012). Endogenous glucocorticoids in inflammation: contributions of systemic and local responses. Swiss Medical Weekly. 142(3132). w13650–w13650. 19 indexed citations

17.

Hardy, Rowan & Mark S. Cooper. (2011). Glucocorticoid-Induced Osteoporosis ? A Disorder of Mesenchymal Stromal Cells?. SHILAP Revista de lepidopterología. 2. 24–24. 20 indexed citations

18.

Tiganescu, Ana, Elizabeth A. Walker, Rowan Hardy, Andrew E. Mayes, & Paul M. Stewart. (2010). Localization, Age- and Site-Dependent Expression, and Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 in Skin. Journal of Investigative Dermatology. 131(1). 30–36. 105 indexed citations

19.

Hardy, Rowan, Marco Eijken, Johannes P.T.M. van Leeuwen, et al.. (2009). Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss. Annals of the Rheumatic Diseases. 69(6). 1185–1190. 53 indexed citations

20.

Hardy, Rowan, Andrew Filer, Mark S. Cooper, et al.. (2006). Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation. Arthritis Research & Therapy. 8(4). R108–R108. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact